Forthcoming articles


International Journal of Healthcare Technology and Management


These articles have been peer-reviewed and accepted for publication in IJHTM, but are pending final changes, are not yet published and may not appear here in their final order of publication until they are assigned to issues. Therefore, the content conforms to our standards but the presentation (e.g. typesetting and proof-reading) is not necessarily up to the Inderscience standard. Additionally, titles, authors, abstracts and keywords may change before publication. Articles will not be published until the final proofs are validated by their authors.


Forthcoming articles must be purchased for the purposes of research, teaching and private study only. These articles can be cited using the expression "in press". For example: Smith, J. (in press). Article Title. Journal Title.


Articles marked with this shopping trolley icon are available for purchase - click on the icon to send an email request to purchase.


Articles marked with this Open Access icon are freely available and openly accessible to all without any restriction except the ones stated in their respective CC licenses.


Register for our alerting service, which notifies you by email when new issues of IJHTM are published online.


We also offer RSS feeds which provide timely updates of tables of contents, newly published articles and calls for papers.


International Journal of Healthcare Technology and Management (2 papers in press)


Regular Issues


  • Emerging product-process archetypes in oncology: informing the sustainable provision of next-generation medicines   Order a copy of this article
    by Tomás S. Harrington, Jagjit Singh Srai, Ismail Najim 
    Abstract: The emergence of more targeted molecular therapies has contributed to accelerated growth within the oncology market, with forecast spends expected to be in the range of $74-84 billion by 2018. Coupled with its many specificities around pricing, insurance implications, and ethics, we argue that the oncology segment may best inform future pharmaceutical value network design characteristics. Through exploration of future state scenarios and opportunity areas, driven by the adoption of emerging process and digital technologies, a base framework is extended to enable a systematic assessment of candidates representative of the wider oncology market. These include niche, low volume drugs on-patent, through to higher volume generics with a history of supply shortages. Oncology archetypes are proposed classified as New Niche, Old Niche and Established Generics matching emerging process capabilities to future adaptive supply requirements, informing the potential for economies of drug repurposing, and associated models for reconfiguration based on benefits clustering.
    Keywords: pharmaceuticals; oncology; value networks; sustainable industrial systems; futures.

  • Enhancing healthcare value by applying proactive measures: the role for business analytics and intelligence   Order a copy of this article
    by Nilmini Wickramasinghe, Jonathan Schaffer 
    Abstract: Healthcare is one of the most data-rich and data-generating industries. Yet, these data tend to be discontinuous, incomplete, lacking standardisation, or even erroneous and unusable. Pressure is increasing for healthcare organisations to provide increased value by improving health outcomes at a lower cost. In order to address these challenges, business analytics and intelligence (BA/BI) are critical strategic tools used to methodically analyse the wealth of seemingly disparate healthcare data sets and provide enhancement of healthcares overall performance through data-driven decision making. For acute and chronic oncology care processes, these pressures are mounting given the rising costs and increasingly complicated processes under the rising numbers and ages of the population. Given these pressures to improve healthcare value, this study proposes a systematic framework for the application of business analytics at one of the largest tertiary hospitals in Melbourne, Australia, in the quest for optimising healthcare.
    Keywords: business analytics; business intelligence; clinical decision making; real-time analytics; evidence-based decisions; cancer treatment; oncology; action research methodology.